Curing sickle cell disease: Mission accomplished?

Pediatric Blood and Cancer

Volumn 62, Issue 7, 2015, Pages 1129-1130

  Lipton, Jeffrey M ^a,b,c  

^a Northwell Health   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ARTICLE; CLINICAL TRIAL (TOPIC); DECISION MAKING; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MORBIDITY; MORTALITY; NEWBORN SCREENING; OVERALL SURVIVAL; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SICKLE CELL ANEMIA; ANEMIA, SICKLE CELL; DONOR; FEMALE; FETUS BLOOD; HISTOCOMPATIBILITY TEST; MALE; SUPPLY AND DISTRIBUTION;

ANEMIA, SICKLE CELL; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; TISSUE DONORS;

EID: 84929514087     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25497     Document Type: Article

References (6)

1. Justus S, Perez-Albuerne E, Dioguardi J, Jacobsohn D, Abraham A. Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease. Pediatr Blood Cancer 2015. doi: 10.1002/pbc.25439. [Epub ahead of print].
2. Shenoy S. Hematopoietic stem-cell transplantation for sickle cell disease: Current evidence and opinions. Ther Adv Hematol 2013; 4:335-344.
3. Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood 2010; 115:3447-3452.
4. Lanzkron S, Carrol CP, Haywood C. Mortality rates and age at death for sickle cell disease: US, 1979-2005. Public Health Rep 2013; 128:110-116.
5. Vichinsky EP. Emerging therapy in hemoglobinopathies: lessons from the past and optimism for the future. Hem/Onc Clin of North Am 2014; 28:xiii-xviii.
6. Odame I. Perspective: We need a global solution. Nature 2014; 515:S10.